Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009316:National Institutes of Health (U.S.); D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D014481:United States
D000970:Antineoplastic Agents